Neupogenn.

Brit.

/ˈnjuːpədʒɛn/,

/ˈnjuːpədʒ(ə)n/, U.S.

/ˈn(j)upəˌdʒɛn/,

/ˈn(j)upədʒ(ə)n/

Forms: also with lower-case initial.

Origin: Perhaps formed within English, by compounding. Etymons: neutrophil adj., -poiesis comb. form, -gen comb. form.

Etymology: Perhaps < neu- (in neutrophil adj.) + -po- (in -poiesis comb. form) + -gen comb. form; compare -ogen comb. form.

Pharmacology.

A proprietary name for: filgrastim.

ΚΠ

1990 Official Gaz. (U.S. Patent Office) 27 Feb. tm40/2 Neupogen... For pharmaceutical preparations—namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell protection [sic].

1991 Sci. Amer. Feb. 110/2 Amgen will begin selling G-CSF (granulocyte colony-stimulating factor), tradenamed Neupogen, to treat the most common and dangerous side-effects of chemotherapy—the destruction of white blood cells that leaves patients prey to bacteria and viruses.

1995 Economist 25 Feb. (Biotechnol. & Genetics Suppl.) 4/1 One company..has both of the industry's biggest selling drugs, neupogen and epogen.

2000 Red Herring May 160/1 A kissing cousin to EPO, Neupogen was designed to stimulate the growth of white blood cells, which are depleted by chemotherapy and by AIDS.

This is a new entry (OED Third Edition, September 2003; most recently modified version published online March 2022).

单词	neupogen
释义	Neupogenn. Brit. /ˈnjuːpədʒɛn/, /ˈnjuːpədʒ(ə)n/, U.S. /ˈn(j)upəˌdʒɛn/, /ˈn(j)upədʒ(ə)n/ Forms: also with lower-case initial. Origin: Perhaps formed within English, by compounding. Etymons: neutrophil adj., -poiesis comb. form, -gen comb. form. Etymology: Perhaps < neu- (in neutrophil adj.) + -po- (in -poiesis comb. form) + -gen comb. form; compare -ogen comb. form. Pharmacology. A proprietary name for: filgrastim. ΚΠ 1990 Official Gaz. (U.S. Patent Office) 27 Feb. tm40/2 Neupogen... For pharmaceutical preparations—namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell protection [sic]. 1991 Sci. Amer. Feb. 110/2 Amgen will begin selling G-CSF (granulocyte colony-stimulating factor), tradenamed Neupogen, to treat the most common and dangerous side-effects of chemotherapy—the destruction of white blood cells that leaves patients prey to bacteria and viruses. 1995 Economist 25 Feb. (Biotechnol. & Genetics Suppl.) 4/1 One company..has both of the industry's biggest selling drugs, neupogen and epogen. 2000 Red Herring May 160/1 A kissing cousin to EPO, Neupogen was designed to stimulate the growth of white blood cells, which are depleted by chemotherapy and by AIDS. This is a new entry (OED Third Edition, September 2003; most recently modified version published online March 2022). < n.1990
随便看	θ9391 θ93910 θ93911 θ93912 θ93913 θ93914 θ93915 θ93916 θ93917 θ93918 θ93919 θ9392 θ93920 θ93921 θ93922 θ93923 θ93924 θ93925 θ93926 θ93927 θ93928 θ93929 θ9393 θ93930 θ93931